Tecentriq 840 mg/14 mL

Tecentriq 840 mg / 14 mL Concentrate for Solution for Infusion Tecentriq 840 mg / 14 mL contains atezolizumab, a monoclonal antibody medicine used in the treatment of certain cancers, including lung cancer and other malignancies. Atezolizumab works by targeting the PD-L1 protein, enabling the immune system to recognize and attack cancer cells more effectively. Tecentriq is administered by intravenous infusion by trained healthcare professionals in a clinical setting as part of a prescribed cancer treatment regimen. Tecentriq 840 mg / 14 mL Concentrate for Solution for Infusion is classified as a prescription-only medicine (POM) and should be used under strict medical supervision. Important Notice Patients receiving Tecentriq should attend scheduled medical appointments and monitoring as part of their oncology treatment plan. Order Tecentriq 840 mg / 14 mL Online Tecentriq 840 mg / 14 mL may be available through licensed online pharmacies and medical supply providers. Always ensure medicines are NAFDAC-approved and obtained from reputable providers to guarantee safety, authenticity, and quality.